Researchers have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age.
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
Marion Nestle, a food policy expert and public health advocate, will share her experience bridging research, policy and public engagement in a talk, “Food Politics: An Agenda for 2024.”
A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new Cornell-led study identifies potential therapies that might one day reverse these unhealthy shifts.
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.
The College of Veterinary Medicine will welcome an embedded counselor to its halls in early November, piloting a new element as part of campus-wide efforts to enhance mental health support.
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators.
A new study that tracks how many asthma-related emergency room visits result from pollen in metropolitan areas across Central Texas highlights the importance of knowing local plants and the need for developing science-based pollen forecasts.
A Cornell-led collaboration developed machine-learning models that use cell-free molecular RNA to diagnose pediatric inflammatory conditions that are difficult to differentiate.